| Vitamin D receptor polymorphisms and diseases JM Valdivielso, E Fernandez Clinica chimica acta 371 (1-2), 1-12, 2006 | 690 | 2006 |
| Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases A Grande-García, A Echarri, J De Rooij, NB Alderson, ... The Journal of cell biology 177 (4), 683-694, 2007 | 382 | 2007 |
| Mineral metabolism parameters throughout chronic kidney disease stages 1–5—achievement of K/DOQI target ranges L Craver, MP Marco, I Martínez, M Rue, M Borràs, ML Martín, F Sarró, ... Nephrology Dialysis Transplantation 22 (4), 1171-1176, 2007 | 357 | 2007 |
| RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4–dependent pathway S Panizo, A Cardus, M Encinas, E Parisi, P Valcheva, S López-Ongil, ... Circulation research 104 (9), 1041-1048, 2009 | 333 | 2009 |
| 1, 25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway A Cardus, E Parisi, C Gallego, M Aldea, E Fernandez, JM Valdivielso Kidney international 69 (8), 1377-1384, 2006 | 281 | 2006 |
| Differential effects of vitamin D analogs on vascular calcification A Cardús, S Panizo, E Parisi, E Fernandez, JM Valdivielso Journal of Bone and Mineral Research 22 (6), 860-866, 2007 | 269 | 2007 |
| Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy MD Sanchez-Niño, AB Sanz, S Carrasco, MA Saleem, PW Mathieson, ... Nephrology Dialysis Transplantation 26 (6), 1797-1802, 2011 | 254 | 2011 |
| Inflammation in diabetic kidney disease RE Pérez-Morales, MD Del Pino, JM Valdivielso, A Ortiz, ... Nephron 143 (1), 12-16, 2019 | 224 | 2019 |
| Atherosclerosis in chronic kidney disease: more, less, or just different? JM Valdivielso, D Rodríguez-Puyol, J Pascual, C Barrios, ... Arteriosclerosis, thrombosis, and vascular biology 39 (10), 1938-1966, 2019 | 221 | 2019 |
| 1, 25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter A Cardus, S Panizo, M Encinas, X Dolcet, C Gallego, M Aldea, ... Atherosclerosis 204 (1), 85-89, 2009 | 214 | 2009 |
| Lipid management in patients with chronic kidney disease CJ Ferro, PB Mark, M Kanbay, P Sarafidis, GH Heine, P Rossignol, ... Nature Reviews Nephrology 14 (12), 727-749, 2018 | 199 | 2018 |
| Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy MD Sanchez-Niño, M Bozic, E Córdoba-Lanús, P Valcheva, O Gracia, ... American Journal of Physiology-Renal Physiology 302 (6), F647-F657, 2012 | 198 | 2012 |
| Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium AR Chang, ME Grams, SH Ballew, H Bilo, A Correa, M Evans, ... bmj 364, 2019 | 191 | 2019 |
| SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by … P Sarafidis, CJ Ferro, E Morales, A Ortiz, J Malyszko, R Hojs, K Khazim, ... Nephrology Dialysis Transplantation 34 (2), 208-230, 2019 | 183 | 2019 |
| Conversion of urine protein–creatinine ratio or urine dipstick protein to urine albumin–creatinine ratio for use in chronic kidney disease screening and prognosis: an … K Sumida, GN Nadkarni, ME Grams, Y Sang, SH Ballew, J Coresh, ... Annals of internal medicine 173 (6), 426-435, 2020 | 180 | 2020 |
| Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis KA Munger, A Montero, M Fukunaga, S Uda, T Yura, E Imai, Y Kaneda, ... Proceedings of the National Academy of Sciences 96 (23), 13375-13380, 1999 | 177 | 1999 |
| F2-isoprostanes mediate high glucose-induced TGF-β synthesis and glomerular proteinuria in experimental type I diabetes A Montero, KA Munger, RZ Khan, JM Valdivielso, JD Morrow, A Guasch, ... Kidney International 58 (5), 1963-1972, 2000 | 143 | 2000 |
| Role of epidermal growth factor receptor (EGFR) and its ligands in kidney inflammation and damage S Rayego-Mateos, R Rodrigues-Diez, JL Morgado-Pascual, F Valentijn, ... Mediators of inflammation 2018, 2018 | 126 | 2018 |
| Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: usefulness of non-invasive tests in cardiovascular assessment B Coll, À Betriu, M Martínez-Alonso, M Borràs, L Craver, ML Amoedo, ... Nephrology Dialysis Transplantation 25 (9), 3017-3025, 2010 | 119 | 2010 |
| Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease L Anguiano, M Riera, J Pascual, JM Valdivielso, C Barrios, A Betriu, ... Nephrology Dialysis Transplantation 30 (7), 1176-1185, 2015 | 118 | 2015 |
